Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies



Summary

Researchers are investigating the plasmablast response triggered by the MMR (measles, mumps, and rubella) vaccine. Their goal is to identify the most prevalent and potent subtypes of plasmablasts generated post-vaccination. By understanding these dominant subtypes, they hope to isolate and characterize the antibodies they produce. Ultimately, this research aims to develop neutralizing antibody-based therapies against measles, mumps, and/or rubella. This could potentially lead to improved treatments and preventative measures against these diseases.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer